Skip to content

    Coromandel Inter

    COROMANDEL
    Chemicals·25 Jul 2025
    Management Summary

    Coromandel International reported strong Q1 FY26 results with significant revenue and EBITDA growth driven by volume expansion and improved subsidy rates. The company made progress on strategic initiatives including the NACL acquisition, BMCC stake increase, and backward integration projects. Despite firm raw material prices, management is confident in sustaining profitability and expanding market presence through product diversification and agri-tech services.

    Highlights

    5
    • Consolidated total income of INR7,126 crores, up 49% YoY from INR4,783 crores in Q1 last year.

    • Consolidated EBITDA of INR782 crores, up 55% YoY from INR506 crores in Q1 last year.

    • Record primary sales volume of 11 lakh tons, marking a 31% growth.

    • Crop Protection and Bio segments revenue grew 31% to Rs 725 crores and EBIT moved up 77% to Rs 111 crores.

    • BMCC output expected to be closer to 300,000 to 400,000 tons per annum this year, with an aim to double in the next 2 years.

    Concerns

    3
    • Raw material prices for processed phosphates (DAP), Phos Acid, and sulfur remained firm or increased in Q1, impacting the value gap.

    • Subsidy outstanding as of June 30, 2025, was INR2,911 crores.

    • DAP market has been tight, though management is confident in future supply from Middle East and new capacities.

    What Changed2

    vs Q2 FY26

    Guidance items16 → 10 (-6)Risks discussed4 → 3 (-1)

    Key financials

    Single quarter

    06 metrics
    1. 01Consolidated Total Income₹7,126 Cr+49%YoY
    2. 02Consolidated EBITDA₹782 Cr+55.0%YoY
    3. 03Subsidy Received₹1,300 Cr
    4. 04Subsidy Outstanding₹2,911 Cr
    5. 05Primary Sales Volume11 lakh tons+31%YoY

    Segment breakdown

    Crop Protection and Bio
    ₹725 Cr Revenue₹111 Cr EBIT
    Bio Business
    100% Volume Growth100% Value Growth
    Specialty Nutrient Business
    12% Volume Growth
    Organic Fertilizer
    29.0% Volume Growth
    SSP Business
    20% Volume Growth1.9 lakh tons Volume
    List

    Capital allocation

    5
    high confidence
    CategoryHeadline
    Capex

    ₹2,000 crores

    Debt

    Debt disclosed

    M&A

    Baobab Mining and Chemicals Corporation (BMCC)

    acquisition · signed

    M&A

    NACL

    acquisition · pending regulatory

    M&A

    Sakarni Plaster

    joint venture · signed

    Guidance & targets

    10
    CategoryTargetPriority
    Capacity
    Kakinada Backward Integration Plant Commissioning
    Commissioned
    High
    Capacity
    Granulation Project Commissioning
    Commissioned
    High
    Capacity
    Granulation Plant Start-up
    January 2027
    High
    Volume
    BMCC Rock Phosphate Output
    300,000 to 400,000 tons per annum
    High
    Volume
    BMCC Rock Phosphate Output Doubling
    Double current output
    High
    Market Penetration
    Drone Spraying Acreage
    0.5 million acres
    High
    Retail Expansion
    New Retail Stores
    400 stores
    High
    Profitability
    EBITDA per Metric Ton
    INR5,000
    High
    M&A
    NACL Acquisition Completion
    Complete transaction
    High
    Capex
    Incremental Capex for Product Categories
    INR300-500 crores
    Medium

    NACL Acquisition Completion

    Q2 FY26
    CurrentAwaiting SEBI clearance
    TargetTransaction completed

    Why it matters

    Completion of this acquisition is key for portfolio expansion and realizing anticipated synergies.

    Hope we get this in Q2 and should be able to complete the transaction.

    How to verify

    capital_allocation.m_and_a[target='NACL'].status

    Risks & concerns

    3
    RiskSeverity

    Raw Material Price Volatility

    Key raw materials like DAP, Phos Acid, and sulfur witnessed firmness or increases in Q1, impacting the value gap, though management aims to sustain normative EBITDA.Management acknowledged

    medium

    DAP Supply Tightness

    The DAP market has been tight, but management is confident that increased volumes from Middle East and new capacities will ease the situation, expecting prices to soften.Management downplayed

    medium

    Challenges in Greenfield Capacity Creation

    Greenfield capacity creation is prohibitive due to high costs and raw material security challenges, leading the company to prefer brownfield or inorganic expansion.Management acknowledged

    low

    Q&A highlights

    8

    “We are evaluating opportunities of creating capacity for some of the key raw materials and as a fertilizer player, our ability to reuse the by-products which are generated out of the process is quite helpful. We are evaluating the investment to create capacities for our captive consumption as well as it provides opportunity for us to export to Europe and various other NPK players globally. Also, it will meet the domestic demand of the rest of the players in the country. On the rare earth minerals. We'll get back to you once we do evaluation. We are trying to focus ourselves mainly on the phosphate-based derivatives. We have not looked at extraction of rare earth minerals.”

    Highlights the company's strategic focus on backward integration for specialty nutrients and its cautious approach to new, unrelated areas like rare earth minerals, indicating a disciplined capital allocation strategy.

    asked by Prashant Biyani

    3 min read6 chapters

    Detailed Narrative

    01

    Q1 FY26 Financial Performance Overview

    Coromandel International reported a robust Q1 FY26, with consolidated total income growing 49% year-on-year to INR7,126 crores, up from INR4,783 crores in Q1 last year. This growth was primarily driven by higher subsidy rates and strong volume growth across all business segments. Consolidated EBITDA saw an even stronger increase of 55% year-on-year, reaching INR782 crores compared to INR506 crores in the previous year's Q1. The company received INR1,300 crores in subsidy claims during the quarter, though INR2,911 crores remained outstanding as of June 30, 2025.

    02

    Operational Highlights and Capacity Expansion

    The company's plants operated at a full capacity of 8.4 lakh tons in Q1, achieving a 6% volume growth. Phosphoric acid volumes increased by 23%, and production of NPK and DAP moved up 6% from 7.88 to 8.37 lakh tons. The backward integration project for phos acid and sulfuric acid at Kakinada is progressing well, with 70% of the project milestone completed, and is expected to be commissioned in Q4 of the current financial year. Additionally, a new granulation project, set to add 7.5 lakh tons of additional capacity, is on track for commissioning by the end of FY26-27.

    03

    Market Dynamics and Product Strategy

    Coromandel achieved a record 11 lakh tons in primary sales volume, marking a 31% growth and securing a close to 18% market share in the NPK segment. POS consumption also saw significant growth, up 46% to 7 lakh tons, with the company's market share on a consumption basis improving to 16% from 12% last year. The focus on unique grades, which differentiate the company, increased their share to 34% of sales, up from 31% last year. Despite firm raw material prices for DAP, Phos Acid, and sulfur, management aims to sustain a normative EBITDA of INR5,000 per metric ton for the year.

    04

    Strategic Investments and Mergers & Acquisitions

    The Board approved increasing the stake in Baobab Mining and Chemicals Corporation (BMCC) by an additional 17.7%, bringing the total ownership to 71.5%, which is crucial for captive rock sourcing. The acquisition of NACL has received Competition Commission approval and is awaiting SEBI clearance, with management targeting completion in Q2 FY26. Furthermore, Coromandel signed a definitive agreement to form a joint venture with Sakarni Plaster to manufacture green building materials, leveraging industrial byproduct gypsum into value-added construction material.

    05

    Crop Protection and Bio Business Performance

    The Crop Protection and Bio segments delivered a robust performance in Q1, with revenue growing 31% to Rs 725 crores and EBIT increasing 77% to Rs 111 crores. The Bio business experienced significant growth, nearly doubling in both volume and value. The company launched 10 new products during the quarter, including one in-licensing product (Nitenpyram), and is intensifying its focus on domestic formulation segments and expanding its geographical presence, with exports contributing 40% to Crop Protection revenue.

    06

    Agri-Tech and Retail Initiatives

    Coromandel is actively promoting agri-tech solutions, with its Gromor Drive drone spraying service covering 25,000 acres in Q1 and targeting at least 0.5 million acres for the current year, emphasizing water conservation. The retail business also performed strongly, opening 73 new stores during the quarter and aiming to add 400 stores this year. The company is enhancing customer outreach through e-commerce platforms, enabling door delivery of agri inputs and providing comprehensive farming solutions.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.